Related Experiment Video
Updated: Jun 22, 2026
08:12
Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm
Published on: December 22, 2016
[Myeloproliferative diseases caused by JAK2 mutation].
1Department of Gastroenterology and Hematology, Faculty of Medicine, Miyazaki University, Kiyotake, Miyazaki 889-1692, Japan.
Rinsho Byori. the Japanese Journal of Clinical Pathology
|June 4, 2009
Summary
The JAK2 V617F mutation drives myeloproliferative diseases like polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF). Its expression level influences disease type, with other mutations also contributing to pathogenesis.
Area of Science:
- Hematology
- Molecular Biology
- Oncology
Context:
- Polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF) are clonal hematopoietic stem cell disorders.
- These myeloproliferative neoplasms (MPNs) share overlapping clinical features and pathogenesis.
- The JAK2 V617F mutation is a key driver in a majority of these MPNs.
Purpose:
- To elucidate the role of the JAK2 V617F mutation in the pathogenesis of MPNs.
- To explore how JAK2 V617F expression levels influence disease phenotype.
- To investigate the contribution of additional somatic mutations in V617F JAK2-positive MPNs.
Summary:
- The JAK2 V617F mutation leads to constitutive JAK-STAT pathway activation, promoting cytokine-independent cell growth.
- Higher JAK2 V617F expression correlates with erythrocytosis (PV), while lower expression is linked to thrombocytosis (ET).
- While JAK2 V617F is critical, other somatic mutations are implicated in the development and diversity of MPNs.
Impact:
- Understanding JAK2 V617F's role and expression provides insights into MPN heterogeneity.
- Identifies potential therapeutic targets within the JAK-STAT pathway.
- Highlights the complex genetic landscape of MPNs beyond the JAK2 mutation.
Related Concept Videos
01:15Differentiation of Common Myeloid Progenitor Cells
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:27Disorders of Leukocytes
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
01:25Immunodeficiency Diseases
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
There are three main causes of immunodeficiency disorders...